Local 12: UC startup gains approval for trials

Portable system from Sense Neuro Diagnostics can detect brain injuires

A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.

Medtech startup Sense Neuro Diagnostics is developing the system, NeuSTAT, to help medical personnel diagnose everything from a traumatic brain injury in battle to a stroke.

“NeuSTAT is a device which will detect blood and for the trial, it’ll be approved to detect blood for someone who may have had a hemorrhagic stroke or bleeding from a traumatic brain injury,” Geoff Klass, CEO of Sense Neuro Diagnostics, said. “Worldwide, there's 50 billion traumatic brain injuries each year, and if you have a traumatic brain injury or if you have a stroke, immediate care is important.”

Sense Neuro Diagnostics hopes for results from the initial trial this year.

See more from Local 12.

Featured image at top: Model of a brain. Photo by Robina Weermeijer on Unsplash

Innovation Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Related Stories

1

Bazinga! UC physicist cracks ‘Big Bang Theory’ problem

December 19, 2025

A physicist at the University of Cincinnati and his colleagues figured out something two of America’s most famous fictional physicists couldn’t: theoretically how to produce subatomic particles called axions in fusion reactors.

2

Broad co-opportunities

December 18, 2025

Sakura Adachi exemplifies the Bearcat spirit: she works hard, she gives back and she takes full advantage of the opportunities the University of Cincinnati offers.